The Clorox Company $CLX Holdings Trimmed by Donald L. Hagan LLC

Donald L. Hagan LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 2.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,248 shares of the company’s stock after selling 229 shares during the period. Donald L. Hagan LLC’s holdings in Clorox were worth $1,230,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Sonora Investment Management Group LLC grew its holdings in shares of Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company’s stock valued at $433,000 after acquiring an additional 72 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Clorox by 0.6% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company’s stock valued at $1,953,000 after acquiring an additional 73 shares in the last quarter. Horizon Investments LLC grew its holdings in shares of Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock valued at $258,000 after acquiring an additional 75 shares in the last quarter. Sfmg LLC grew its holdings in shares of Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company’s stock valued at $409,000 after acquiring an additional 76 shares in the last quarter. Finally, Hancock Whitney Corp grew its holdings in shares of Clorox by 4.3% during the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock valued at $304,000 after acquiring an additional 86 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CLX shares. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a report on Monday, September 8th. UBS Group decreased their price objective on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a report on Thursday, July 17th. Jefferies Financial Group decreased their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a report on Thursday, June 26th. Citigroup reiterated a “neutral” rating and issued a $135.00 price objective (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Finally, Wells Fargo & Company decreased their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average price target of $141.09.

Clorox Stock Up 0.3%

CLX stock opened at $123.32 on Wednesday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a 50-day moving average of $123.33 and a two-hundred day moving average of $130.02. The stock has a market capitalization of $15.08 billion, a price-to-earnings ratio of 18.91, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the company earned $1.82 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.